{"id":19162,"date":"2020-03-25T12:53:35","date_gmt":"2020-03-25T11:53:35","guid":{"rendered":"http:\/\/miunidad.eu\/porib.com\/?p=19162"},"modified":"2022-07-06T12:54:48","modified_gmt":"2022-07-06T10:54:48","slug":"tratamiento-con-alectinib-para-pacientes-con-metastasis-cerebrales","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/tratamiento-con-alectinib-para-pacientes-con-metastasis-cerebrales\/","title":{"rendered":"Tratamiento con alectinib para pacientes con met\u00e1stasis cerebrales"},"content":{"rendered":"<p>El tratamiento con alectinib para pacientes con met\u00e1stasis cerebrales puede suponer una reducci\u00f3n de costes frente a crizotinib, seg\u00fan se desprende del art\u00edculo publicado en Lung Cancer Management: Cost analysis of the management of brain metastases in patients with advanced ALK+ NSCLC: alectinib versus crizotinib, de los autores Isla D, Massuti B, L\u00e1zaro M, Ruiz de Alda L, Gordo R, Ortega-Joaqu\u00edn N, Oyag\u00fcez I.<\/p>\n<p>M\u00c1S INFORMACI\u00d3N: <a href=\"https:\/\/www.futuremedicine.com\/doi\/10.2217\/lmt-2019-0011\">https:\/\/www.futuremedicine.com\/doi\/10.2217\/lmt-2019-0011<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El tratamiento con alectinib para pacientes con met\u00e1stasis cerebrales puede suponer una reducci\u00f3n de costes frente a crizotinib, seg\u00fan se desprende del art\u00edculo publicado en Lung Cancer Management: Cost analysis of the management of brain metastases in patients with advanced ALK+ NSCLC: alectinib versus crizotinib, de los autores Isla D, Massuti B, L\u00e1zaro M, Ruiz&#8230; <\/p>\n<div class=\"clear\"><\/div>\n<p><a href=\"https:\/\/porib.com\/en\/tratamiento-con-alectinib-para-pacientes-con-metastasis-cerebrales\/\" class=\"excerpt-read-more\">Read More<i class=\"fa fa-caret-right icon-caret-right\"><\/i><\/a><\/p>\n","protected":false},"author":4,"featured_media":19163,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[67],"tags":[],"class_list":["post-19162","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ultimas-noticias"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/19162"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=19162"}],"version-history":[{"count":1,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/19162\/revisions"}],"predecessor-version":[{"id":19164,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/19162\/revisions\/19164"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media\/19163"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=19162"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=19162"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=19162"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}